Should procalcitonin be measured routinely in acute decompensated heart failure?

被引:4
|
作者
Loncar, Goran [1 ]
Tscholl, Verena [2 ]
Tahirovic, Elvis [2 ]
Sekularac, Nikola [1 ]
Marx, Almuth [3 ]
Obradovic, Danilo [2 ]
Veskovic, Jovan [2 ]
Lainscak, Mitja [4 ,5 ,6 ]
von Haehling, Stephan [7 ,8 ]
Edelmann, Frank [2 ]
Arandjelovic, Aleksandra [1 ,9 ]
Apostolovic, Svetlana [10 ]
Stanojevic, Dragana [10 ]
Pieske, Burkert [2 ]
Trippel, Tobias [2 ]
Dungen, Hans-Dirk [2 ]
机构
[1] Clin Hosp Zvezdara, Dept Cardiol, Belgrade, Serbia
[2] Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Marx Stat, Nurnberg, Germany
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Gen Hosp Celje, Dept Res & Educ, Celje, Slovenia
[6] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[7] Charite, Appl Cachexia Res, Dept Cardiol, Berlin, Germany
[8] Charite, CCR, Berlin, Germany
[9] Univ Belgrade, Sch Med, Belgrade 11001, Serbia
[10] Clin Ctr Nis, Clin Cardiovasc Dis, Nish, Serbia
关键词
ADHF; NT-proBNP; procalcitonin; prognosis; serial measurements; CRITICALLY-ILL PATIENTS; NATRIURETIC PEPTIDE; IMMUNE ACTIVATION; CARDIOGENIC-SHOCK; DIAGNOSIS; BIOMARKERS; MORTALITY; INFECTION; ENDOTOXIN; INCREASE;
D O I
10.2217/BMM.15.29
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: To elucidate the prognostic role of procalcitonin (PCT) in patients with acute decompensated heart failure (ADHF) without clinical signs of infection at admission. Materials & Methods: Serial measurements of PCT and NT-proBNP were performed in 168 patients, aged 68 +/- 10 years with ADHF followed by 3-month outcome evaluation. Results: Cox regression analysis demonstrated significant predictive value of baseline PCT for all-cause death/hospitalization (area under the curve: 0.67; p = 0.013) at 90th day. The patients with persistently elevated PCT or with an increase during the first 72 h of hospitalization had the worst prognosis (p = 0.0002). Conclusion: Baseline and serial in-hospital measurements of PCT have significant prognostic properties for 3-month all-cause mortality/hospitalization in patients with ADHF without clinical signs of infection at admission.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 50 条
  • [21] The challenge of acute decompensated heart failure
    Faiez Zannad
    Chris Adamopoulos
    Alexandre Mebazaa
    Mihai Gheorghiade
    Heart Failure Reviews, 2006, 11 : 135 - 139
  • [22] Management of Acute Decompensated Heart Failure
    Varughese, Sheeba
    CRITICAL CARE NURSING QUARTERLY, 2007, 30 (02) : 94 - 103
  • [23] Acute Dyspnea and Decompensated Heart Failure
    Pang, Peter S.
    Collins, Sean P.
    Gheorghiade, Mihai
    Butler, Javed
    CARDIOLOGY CLINICS, 2018, 36 (01) : 63 - +
  • [24] Acute decompensated heart failure: An introduction
    Smith, Eldon R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 : 5B - 5B
  • [25] Acetazolamide in Acute Decompensated Heart Failure
    Pai, Ramdas G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (13)
  • [26] Management of acute decompensated heart failure
    William, G.
    CURRENT PROBLEMS IN CARDIOLOGY, 2007, 32 (06) : 321 - 366
  • [27] Disparities in acute decompensated heart failure
    Miller, Tamari
    Carter, Spencer V.
    Smith, Bryan A.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (03) : 335 - 339
  • [28] Managing Acute Decompensated Heart Failure
    Pauly, Daniel F.
    CARDIOLOGY CLINICS, 2014, 32 (01) : 145 - +
  • [29] The challenge of acute decompensated heart failure
    Zannad, Faiez
    Adamopoulos, Chris
    Mebazaa, Alexandre
    Gheorghiade, Mihai
    HEART FAILURE REVIEWS, 2006, 11 (02) : 135 - 139
  • [30] Acute Decompensated Heart Failure Update
    Teerlink, John R.
    Alburikan, Khalid
    Metra, Marco
    Rodgers, Jo E.
    CURRENT CARDIOLOGY REVIEWS, 2015, 11 (01) : 53 - 62